PUBLISHER: 360iResearch | PRODUCT CODE: 1718090
PUBLISHER: 360iResearch | PRODUCT CODE: 1718090
Gut Health Nutraceuticals Market by Product, Form, Distribution Chanel - Global Forecast 2025-2030
The Gut Health Nutraceuticals Market was valued at USD 12.24 billion in 2024 and is projected to grow to USD 13.12 billion in 2025, with a CAGR of 7.46%, reaching USD 18.85 billion by 2030.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2024] | USD 12.24 billion |
| Estimated Year [2025] | USD 13.12 billion |
| Forecast Year [2030] | USD 18.85 billion |
| CAGR (%) | 7.46% |
The global gut health nutraceuticals market is experiencing an unprecedented evolution, marking a pivotal moment for stakeholders. In recent years, increased consumer awareness and a growing emphasis on preventive health care have spurred significant interest in products that promote digestive health and overall wellness. This comprehensive analysis examines the market landscape, technological innovations, and evolving consumer dynamics that are shaping the future of gut health nutrition.
Several factors including the rise of chronic digestive disorders, an aging population, and heightened interest in natural health ingredients have contributed to market expansion. The narrative is supported by in-depth research and a detailed overview of emerging trends that underscore the importance of a healthy gut in achieving balanced wellness.
By delving into product innovations, distribution strategies, and the competitive ecosystem, this summary lays the groundwork for professionals seeking to capitalize on new opportunities and optimize their strategic positioning. The insights provided herein are tailored for experts and decision-makers who value precise, actionable information to forecast market dynamics and guide future initiatives.
Transformative Shifts in the Gut Health Nutraceuticals Landscape
Over recent years, the market has witnessed transformative shifts that have redefined how companies approach product development and consumer engagement. Innovations in formulation, an increasing reliance on scientific research, and a growing emphasis on quality control have led to the introduction of novel ingredients and delivery systems that enhance the efficacy of gut health products.
The industry's evolution is marked by a transition from traditional supplement delivery methods to more integrated solutions that offer improved bioavailability and consumer convenience. With research continuously uncovering the critical role of gut microbiota in overall health, manufacturers are now employing advanced techniques to harness the power of natural ingredients. This shift is not just reflective of changing consumer preferences; it is also driven by a demand for transparency and clinically backed evidence, making product innovation a key competitive differentiator.
Furthermore, the emergence of personalized nutrition trends and tailored supplement regimens have allowed companies to better target specific consumer needs. Collaboration between industry leaders, academic institutions, and technological innovators has fostered a landscape where disruptive ideas are rapidly translated into market-ready products. These changes have redefined industry benchmarks, positioning the sector to meet the evolving demands of a health-conscious global audience.
Key Segmentation Insights Driving Market Dynamics
A detailed examination of market segmentation reveals significant nuances that influence market growth and strategic investment decisions. The segmentation based on product offers a clear framework, with the market being studied across enzymes, fulvic acid, postbiotics, prebiotics, and probiotics. Each of these product categories addresses different aspects of gut health, catering to the diverse needs of consumers seeking to enhance their digestive well-being.
The segmentation based on form further dissects the market into formats such as capsules/tablets, gummies, liquids, and powders. These various formats offer differing benefits in terms of ease of consumption, bioavailability, and consumer preference, providing flexibility and choice to the end user. Such variety caters to a broad demographic, ensuring that there is an optimal solution available for every lifestyle.
Distribution channel analysis further enriches the segmentation insights by considering both offline and online pathways. Offline channels, subdivided into drug stores and pharmacies as well as supermarkets and hypermarkets, continue to play a crucial role in reaching traditional consumers. In parallel, online channels, which include brand websites and eCommerce platforms, have opened up new avenues for market penetration, making it easier for consumers to access specialized gut health products from the comfort of their homes. Overall, these segmentation insights shed light on diverse market trends, providing a roadmap for future product development and targeted marketing strategies.
Based on Product, market is studied across Enzymes, Fulvic Acid, Postbiotics, Prebiotics, and Probiotics.
Based on Form, market is studied across Capsules/Tablets, Gummies, Liquids, and Powders.
Based on Distribution Chanel, market is studied across Offline and Online. The Offline is further studied across Drug Stores & Pharmacies and Supermarkets/Hypermarkets. The Online is further studied across Brand Websites and eCommerce Platforms.
Key Regional Insights Fueling Market Expansion
The regional analysis of the market underscores the significance of geographic diversity in shaping consumer behavior and business strategies. In the Americas, the market is buoyed by a strong trend towards preventive healthcare, driven by rising health awareness and a robust distribution network that rapidly disseminates new product offerings. Manufacturers in this region are increasingly investing in digital marketing channels and direct-to-consumer models, fostering an environment that encourages streamlined product access and enhanced consumer engagement.
In the vast and varied regions of Europe, the Middle East, and Africa, shifting regulatory frameworks and consumer skepticism toward synthetic ingredients have resulted in a heightened interest in natural and scientifically validated products. This region's heterogeneous cultural landscape is prompting companies to tailor their product offerings to meet local tastes and regulatory demands. Progressive policies and collaborations with research institutions have further boosted innovation and product credibility.
Asia-Pacific presents a unique case where rapid urbanization and a surge in disposable income are fueling consumer inclination towards premium health supplements. The increased integration of traditional wellness philosophies with modern science has positioned this region as a hotbed for product innovation. Consumers in Asia-Pacific are highly receptive to trends that offer both holistic well-being and evidence-based formulations, driving market demand and rendering this region one of the fastest growing on a global scale.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Key Companies Shaping the Future of Gut Health Nutraceuticals
The competitive landscape in the gut health nutraceuticals market is defined by the presence of major industry players and emerging innovators who are striving to capture a significant share of the market. Prestigious names such as Abbott Laboratories and Amway Corporation by Alticor Global Holdings Inc. have long been recognized for their robust research and product innovation capabilities. Their strategic investments in next-generation formulations set the tone for quality and reliability in the industry.
Other influential corporations including Archer-Daniels-Midland Company, BASF SE, and Bayer AG continue to drive market trends through their expansive product portfolios and extensive global reach. The market is further enriched by the contributions of established entities like Chr. Hansen A/S by Novonesis, Danone S.A., and DSM-Firmenich AG who bring in-depth expertise in probiotic formulations and scientific research.
DuPont de Nemours, Inc., FANCL Corporation by Kirin Holdings Company, and GNC Holdings, LLC have also carved out significant market segments with innovative product lines that emphasize formulation efficiency and nutrient synergy. Notably, major brands such as Herbalife International of America, Inc., Himalaya Wellness Company, Kerry Group plc, and Lonza Group Ltd. have advanced consumer trust by continuously evolving their product offerings. Progressive companies including Manitoba Harvest by Tilray Brands, Inc., Nestle S.A., NOW Health Group, Inc., Pfizer Inc., Probi AB, Sanofi S.A., and Symrise AG underscore a trend toward rigorous quality standards and scientific validation. The landscape is further diversified by influential players such as The Procter & Gamble Company, TruBiotics by PanTheryx, Inc., Yakult Honsha Co.,Ltd., and Zenwise, LLC, whose ongoing commitment to innovation and consumer-centric strategies continues to shape the sector's future.
The report delves into recent significant developments in the Gut Health Nutraceuticals Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amway Corporation by Alticor Global Holdings Inc., Archer-Daniels-Midland Company, BASF SE, Bayer AG, Chr. Hansen A/S by Novonesis, Danone S.A., DSM-Firmenich AG, DuPont de Nemours, Inc., FANCL Corporation by Kirin Holdings Company, GNC Holdings, LLC, Herbalife International of America, Inc., Himalaya Wellness Company, Kerry Group plc, Lonza Group Ltd., Manitoba Harvest by Tilray Brands, Inc., Nestle S.A., NOW Health Group, Inc., Pfizer Inc., Probi AB, Sanofi S.A., Symrise AG, The Procter & Gamble Company, TruBiotics by PanTheryx, Inc., Yakult Honsha Co.,Ltd., and Zenwise, LLC. Actionable Recommendations for Industry Leaders in Gut Health Nutraceuticals
For industry leaders and decision-makers, the current market dynamics necessitate a forward-thinking approach that prioritizes innovation, research, and consumer engagement. Companies should invest in robust R&D initiatives to explore novel formulations that not only cater to current consumer demands but also anticipate future trends based on emerging scientific insights. Emphasizing quality control and clinical validation will be critical to building consumer trust in an increasingly competitive market.
Strategically, companies are encouraged to explore partnerships with academic institutions and research laboratories to foster a pipeline of innovative solutions. Investment in digital marketing and eCommerce platforms is no longer optional; it is imperative for capturing a broader market share and enhancing direct consumer relationships. Additionally, exploring diversification across product forms-from capsules and gummies to liquids and powders-can provide a competitive edge by catering to varied consumer preferences.
Enhancing distribution networks by maintaining a robust offline presence in traditional pharmacies and supermarkets, while simultaneously expanding online channels via dedicated brand websites and eCommerce platforms, will ensure that products remain accessible to a diverse consumer base. Moreover, adopting a region-specific approach that accounts for varying regulatory environments and consumer behavior will optimize market penetration globally. In essence, a balanced strategy that incorporates innovation, quality assurance, and strategic omnichannel distribution is essential for securing a dominant position in the evolving gut health nutraceuticals landscape.
Conclusion: Navigating the Evolving Gut Health Nutraceuticals Arena
In conclusion, the gut health nutraceuticals market stands at a critical juncture where technological advancements, comprehensive segmentation, and dynamic regional trends intertwine to form a complex but promising landscape. The progression from traditional supplement paradigms to advanced, science-backed formulations reflects a broader shift in consumer behavior and industry standards. As companies innovate in product development and distribution, they are also setting new benchmarks for efficacy, safety, and consumer satisfaction.
This analysis reaffirms that market success hinges on the ability to adapt to evolving scientific discoveries and regulatory frameworks. Stakeholders must remain agile, continuously monitoring market trends to anticipate changes and leverage new opportunities. Whether through enhancing product portfolios, optimizing distribution channels, or forging strategic partnerships, companies are advised to adopt a holistic approach that does not merely react to market trends but actively shapes them.
Overall, the insights presented in this summary provide a clear roadmap for those looking to navigate the complexities of the gut health nutraceuticals arena. With a strong emphasis on innovation, consumer-centric strategies, and regional adaptability, the market is poised for sustained growth and transformative progress.
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing prevalence of gastrointestinal disorders worldwide
- 5.1.1.2. Rising consumer awareness of the benefits of gut health supplements
- 5.1.1.3. Expanding e-commerce channels and improved retail distribution networks
- 5.1.1.4. Growing preference for natural and plant-based nutraceutical products
- 5.1.2. Restraints
- 5.1.2.1. High R&D costs and potential risk of product recalls
- 5.1.3. Opportunities
- 5.1.3.1. Potential for personalized nutrition for tailored gut health solutions
- 5.1.3.2. Surging partnerships & collaboration to advance gut health nutraceuticals
- 5.1.4. Challenges
- 5.1.4.1. Skepticism about the efficacy of nutraceutical products
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.2.1. Product: Growing usage of fulvic acid in enhancing nutrient absorption and detoxifying the gut
- 5.2.2. Form: Rising demand for gut health nutraceutical gummies owing to the appealing taste and ease of consumption
- 5.2.3. Distribution Chanel: Surging preference for online distribution channel for better convenience and extensive product information
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Gut Health Nutraceuticals Market, by Product
- 6.1. Introduction
- 6.2. Enzymes
- 6.3. Fulvic Acid
- 6.4. Postbiotics
- 6.5. Prebiotics
- 6.6. Probiotics
7. Gut Health Nutraceuticals Market, by Form
- 7.1. Introduction
- 7.2. Capsules/Tablets
- 7.3. Gummies
- 7.4. Liquids
- 7.5. Powders
8. Gut Health Nutraceuticals Market, by Distribution Chanel
- 8.1. Introduction
- 8.2. Offline
- 8.2.1. Drug Stores & Pharmacies
- 8.2.2. Supermarkets/Hypermarkets
- 8.3. Online
- 8.3.1. Brand Websites
- 8.3.2. eCommerce Platforms
9. Americas Gut Health Nutraceuticals Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Gut Health Nutraceuticals Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Gut Health Nutraceuticals Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. Market Share Analysis, 2024
- 12.2. FPNV Positioning Matrix, 2024
- 12.3. Competitive Scenario Analysis
- 12.3.1. ResM GLP-1 postbiotic redefines gut health and metabolic function with a science-backed blend
- 12.3.2. Pooch & Mutt acquires pet gut health firm Biome9
- 12.3.3. MicrobioTx launches a personalized probiotic range using Indian gut profile data
- 12.3.4. Designs for Health launches 3R gut reset supplement program with IgGI shield capsules and personalized testing
- 12.3.5. Amway taps into emerging gut health science and lifestyle changes to support wellbeing
- 12.3.6. Paine Schwartz acquires Promix to expand presence in gut health nutraceuticals
- 12.3.7. Sova Health introduces Sova X, Asia's first personalized probiotic nutraceutical
- 12.3.8. Symise launches innovative nutraceutical solutions for enhanced gut health
- 12.3.9. Bene Esse launched plant-based gut health nutraceuticals transforming digestive wellness
- 12.3.10. SIRIO Pharma launches the innovative GummiBiotic range at CPHI Milan
- 12.3.11. Aurelle Health launches innovative gut health nutraceutical in India
- 12.3.12. Manitoba Harvest and Brightseed partner on innovative coffee and chocolate organic bioactive fiber supplements to enhance gut health
- 12.3.13. Sova Health secures USD 1 million seed funding for new product innovations and market expansion
- 12.3.14. dsm-firmenich partners with Lallemand Health Solutions
- 12.3.15. NutriLeads secured EUR 4.5 million in Series C funding to advance the commercialization of BeniCaros
- 12.3.16. Acutia launches holistic dietary supplement for digestive health in compostable packaging
- 12.3.17. Nestle Health Science launches 'Resource Fiber Choice' to improve gut health
- 12.3.18. Nutrazee Unveils Probiotic Gummies For Digestive And Immune Health
- 12.4. Strategy Analysis & Recommendation
- 12.4.1. Amway Corporation by Alticor Global Holdings Inc.
- 12.4.2. Yakult Honsha Co.,Ltd.
- 12.4.3. Nestle S.A.
- 12.4.4. DSM-Firmenich AG
Companies Mentioned
- 1. Abbott Laboratories
- 2. Amway Corporation by Alticor Global Holdings Inc.
- 3. Archer-Daniels-Midland Company
- 4. BASF SE
- 5. Bayer AG
- 6. Chr. Hansen A/S by Novonesis
- 7. Danone S.A.
- 8. DSM-Firmenich AG
- 9. DuPont de Nemours, Inc.
- 10. FANCL Corporation by Kirin Holdings Company
- 11. GNC Holdings, LLC
- 12. Herbalife International of America, Inc.
- 13. Himalaya Wellness Company
- 14. Kerry Group plc
- 15. Lonza Group Ltd.
- 16. Manitoba Harvest by Tilray Brands, Inc.
- 17. Nestle S.A.
- 18. NOW Health Group, Inc.
- 19. Pfizer Inc.
- 20. Probi AB
- 21. Sanofi S.A.
- 22. Symrise AG
- 23. The Procter & Gamble Company
- 24. TruBiotics by PanTheryx, Inc.
- 25. Yakult Honsha Co.,Ltd.
- 26. Zenwise, LLC
LIST OF FIGURES
- FIGURE 1. GUT HEALTH NUTRACEUTICALS MARKET MULTI-CURRENCY
- FIGURE 2. GUT HEALTH NUTRACEUTICALS MARKET MULTI-LANGUAGE
- FIGURE 3. GUT HEALTH NUTRACEUTICALS MARKET RESEARCH PROCESS
- FIGURE 4. GUT HEALTH NUTRACEUTICALS MARKET SIZE, 2024 VS 2030
- FIGURE 5. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 6. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
- FIGURE 7. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
- FIGURE 9. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
- FIGURE 11. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
- FIGURE 12. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2024 VS 2030 (%)
- FIGURE 13. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2024 VS 2025 VS 2030 (USD MILLION)
- FIGURE 14. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
- FIGURE 15. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
- FIGURE 16. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
- FIGURE 17. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
- FIGURE 18. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
- FIGURE 19. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
- FIGURE 22. GUT HEALTH NUTRACEUTICALS MARKET SHARE, BY KEY PLAYER, 2024
- FIGURE 23. GUT HEALTH NUTRACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2024
LIST OF TABLES
- TABLE 1. GUT HEALTH NUTRACEUTICALS MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
- TABLE 3. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. GUT HEALTH NUTRACEUTICALS MARKET DYNAMICS
- TABLE 7. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FULVIC ACID, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY POSTBIOTICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY CAPSULES/TABLETS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY GUMMIES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 18. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 19. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 20. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DRUG STORES & PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 21. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY SUPERMARKETS/HYPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 22. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 23. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 24. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY BRAND WEBSITES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 25. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 26. GLOBAL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 27. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 28. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 29. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 30. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 31. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 32. AMERICAS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 33. ARGENTINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 34. ARGENTINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 35. ARGENTINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 36. ARGENTINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 37. ARGENTINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 38. BRAZIL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 39. BRAZIL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 40. BRAZIL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 41. BRAZIL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 42. BRAZIL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 43. CANADA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 44. CANADA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 45. CANADA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 46. CANADA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 47. CANADA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 48. MEXICO GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 49. MEXICO GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 50. MEXICO GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 51. MEXICO GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 52. MEXICO GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 53. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 54. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 55. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 56. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 57. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 58. UNITED STATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 59. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 60. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 61. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 62. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 63. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 64. ASIA-PACIFIC GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 65. AUSTRALIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 66. AUSTRALIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 67. AUSTRALIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 68. AUSTRALIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 69. AUSTRALIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 70. CHINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 71. CHINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 72. CHINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 73. CHINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 74. CHINA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 75. INDIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 76. INDIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 77. INDIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 78. INDIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 79. INDIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 80. INDONESIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 81. INDONESIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 82. INDONESIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 83. INDONESIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 84. INDONESIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 85. JAPAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 86. JAPAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 87. JAPAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 88. JAPAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 89. JAPAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 90. MALAYSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 91. MALAYSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 92. MALAYSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 93. MALAYSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 94. MALAYSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 95. PHILIPPINES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 96. PHILIPPINES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 97. PHILIPPINES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 98. PHILIPPINES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 99. PHILIPPINES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 100. SINGAPORE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 101. SINGAPORE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 102. SINGAPORE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 103. SINGAPORE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 104. SINGAPORE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 105. SOUTH KOREA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 106. SOUTH KOREA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 107. SOUTH KOREA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 108. SOUTH KOREA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 109. SOUTH KOREA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 110. TAIWAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 111. TAIWAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 112. TAIWAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 113. TAIWAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 114. TAIWAN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 115. THAILAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 116. THAILAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 117. THAILAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 118. THAILAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 119. THAILAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 120. VIETNAM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 121. VIETNAM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 122. VIETNAM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 123. VIETNAM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 124. VIETNAM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 125. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 126. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 127. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 128. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 129. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 130. EUROPE, MIDDLE EAST & AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 131. DENMARK GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 132. DENMARK GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 133. DENMARK GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 134. DENMARK GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 135. DENMARK GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 136. EGYPT GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 137. EGYPT GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 138. EGYPT GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 139. EGYPT GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 140. EGYPT GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 141. FINLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 142. FINLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 143. FINLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 144. FINLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 145. FINLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 146. FRANCE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 147. FRANCE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 148. FRANCE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 149. FRANCE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 150. FRANCE GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 151. GERMANY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 152. GERMANY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 153. GERMANY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 154. GERMANY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 155. GERMANY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 156. ISRAEL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 157. ISRAEL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 158. ISRAEL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 159. ISRAEL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 160. ISRAEL GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 161. ITALY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 162. ITALY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 163. ITALY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 164. ITALY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 165. ITALY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 166. NETHERLANDS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 167. NETHERLANDS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 168. NETHERLANDS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 169. NETHERLANDS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 170. NETHERLANDS GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 171. NIGERIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 172. NIGERIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 173. NIGERIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 174. NIGERIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 175. NIGERIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 176. NORWAY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 177. NORWAY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 178. NORWAY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 179. NORWAY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 180. NORWAY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 181. POLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 182. POLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 183. POLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 184. POLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 185. POLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 186. QATAR GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 187. QATAR GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 188. QATAR GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 189. QATAR GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 190. QATAR GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 191. RUSSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 192. RUSSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 193. RUSSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 194. RUSSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 195. RUSSIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 196. SAUDI ARABIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 197. SAUDI ARABIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 198. SAUDI ARABIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 199. SAUDI ARABIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 200. SAUDI ARABIA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 201. SOUTH AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 202. SOUTH AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 203. SOUTH AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 204. SOUTH AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 205. SOUTH AFRICA GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 206. SPAIN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 207. SPAIN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 208. SPAIN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 209. SPAIN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 210. SPAIN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 211. SWEDEN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 212. SWEDEN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 213. SWEDEN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 214. SWEDEN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 215. SWEDEN GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 216. SWITZERLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 217. SWITZERLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 218. SWITZERLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 219. SWITZERLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 220. SWITZERLAND GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 221. TURKEY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 222. TURKEY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 223. TURKEY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 224. TURKEY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 225. TURKEY GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 226. UNITED ARAB EMIRATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 227. UNITED ARAB EMIRATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 228. UNITED ARAB EMIRATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 229. UNITED ARAB EMIRATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 230. UNITED ARAB EMIRATES GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 231. UNITED KINGDOM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 232. UNITED KINGDOM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 233. UNITED KINGDOM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANEL, 2018-2030 (USD MILLION)
- TABLE 234. UNITED KINGDOM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
- TABLE 235. UNITED KINGDOM GUT HEALTH NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
- TABLE 236. GUT HEALTH NUTRACEUTICALS MARKET SHARE, BY KEY PLAYER, 2024
- TABLE 237. GUT HEALTH NUTRACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2024
